Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Athanassakis

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Immunology|November 22, 2017
Soluble major histocompatibility complex molecules in immune regulation: highlighting class II antigensKaterina Bakela, Irene Athanassakis
Recent Patents on Inflammation & Allergy Drug Discovery|December 17, 2008
Recent knowledge and new pharmaceutical products in potential alleviation of endometriosisSimon Vassiliadis, Irene Athanassakis
Immunology|November 9, 2002
Interplay between T helper type 1 and type 2 cytokines and soluble major histocompatibility complex molecules: a paradigm in pregnancyIrene Athanassakis, S Vassiliadis
Fertility and Sterility|May 31, 2011
A "conditionally essential" nutrient, L-carnitine, as a primary suspect in endometriosisSimon Vassiliadis, Irene Athanassakis
Vaccine|April 28, 2022
SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?Tania Antonopoulou, Irene Athanassakis
Russian Journal of Immunology : RJI : Official Journal of Russian Society of Immunology|April 11, 2003
Preventive Immunotherapy for High-Risk AbortersSimon Vassiliadis, Irene Athanassakis
Shock (Augusta, Ga.)|July 7, 2017
Protection Against Lipopolysaccharide-Induced Immunosuppression by IgG and IgMChristiana Kyvelidou, Dimitris Sotiriou, Ioanna Zerva, et al.
European Journal of Immunology|February 5, 2013
Gender equality: is it real?Katja Simon, Irene Athanassakis, Fiona Powrie, et al.
Immunology|July 24, 2014
Soluble MHC-II proteins promote suppressive activity in CD4+ T cellsKaterina Bakela, Nikos Kountourakis, Michalis Aivaliotis, et al.
Pharmaceutical Biology|April 8, 2015
T cell regulation by Phlomis lanata protein extracts in miceDebora Karali, Luciana Georgescu, Stergios Pirintsos, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Immunology|November 22, 2017
Soluble major histocompatibility complex molecules in immune regulation: highlighting class II antigensKaterina Bakela, Irene Athanassakis
Recent Patents on Inflammation & Allergy Drug Discovery|December 17, 2008
Recent knowledge and new pharmaceutical products in potential alleviation of endometriosisSimon Vassiliadis, Irene Athanassakis
Immunology|November 9, 2002
Interplay between T helper type 1 and type 2 cytokines and soluble major histocompatibility complex molecules: a paradigm in pregnancyIrene Athanassakis, S Vassiliadis
Fertility and Sterility|May 31, 2011
A "conditionally essential" nutrient, L-carnitine, as a primary suspect in endometriosisSimon Vassiliadis, Irene Athanassakis
Vaccine|April 28, 2022
SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?Tania Antonopoulou, Irene Athanassakis
Russian Journal of Immunology : RJI : Official Journal of Russian Society of Immunology|April 11, 2003
Preventive Immunotherapy for High-Risk AbortersSimon Vassiliadis, Irene Athanassakis
Shock (Augusta, Ga.)|July 7, 2017
Protection Against Lipopolysaccharide-Induced Immunosuppression by IgG and IgMChristiana Kyvelidou, Dimitris Sotiriou, Ioanna Zerva, et al.
European Journal of Immunology|February 5, 2013
Gender equality: is it real?Katja Simon, Irene Athanassakis, Fiona Powrie, et al.
Immunology|July 24, 2014
Soluble MHC-II proteins promote suppressive activity in CD4+ T cellsKaterina Bakela, Nikos Kountourakis, Michalis Aivaliotis, et al.
Pharmaceutical Biology|April 8, 2015
T cell regulation by Phlomis lanata protein extracts in miceDebora Karali, Luciana Georgescu, Stergios Pirintsos, et al.
Pageof 4